Trial Profile
Phase II of oral satraplatin in patients with metastatic breast cancer (MBC).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Satraplatin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 22 Mar 2012 Actual patient (40) as reported by ClinicalTrials.gov.
- 14 Feb 2008 The expected completion date for this trial is now 1 Feb 2008.
- 05 Feb 2008 Status changed from in progress to completed according to NCT.